Results 41 to 50 of about 141,935 (272)
Les Cancers Digestifs au Burkina Faso : Aspects Épidémiologiques, Diagnostiques et Thérapeutiques
RESUME Introduction. Au Burkina Faso, les cancers digestifs entraînent une mortalité disproportionnée en raison d'un diagnostic tardif, reflétant un défi majeur de santé publique en Afrique subsaharienne.
Sanné Zitgnimian Souleymane +6 more
doaj +1 more source
La maladie à IgG4: à propos de 3 cas
La maladie à IgG4 encore appelée polyexocrinopathie auto-immune à IgG4 est une nouvelle entité où s´inscrit la PAI de type 1. Elle peut toucher différents organes (système nerveux central, les glandes salivaires, la thyroïde, les poumons, le pancréas ...
Hakima Abid +11 more
doaj +1 more source
Heterogeneous cancer‐associated fibroblasts orchestrate dual immune microenvironments in LAGC. Abstract The potential for immunotherapy in patients with locally advanced gastric cancer (LAGC) is recently confirmed. To report the 3‐year follow‐up data are aimed from a novel clinical trial. This is a prospective single‐arm phase II trial.
Yao Lin +14 more
wiley +1 more source
INTRODUCTION: La baisse de la densité minérale osseuse représente la principale manifestation osseuse décrite au cours des maladies inflammatoires chroniques de l'intestin.
Aida Ben Slama Trabelsi +8 more
doaj +1 more source
Aims To translate a PBPK model developed for the direct oral anticoagulant, dabigatran etexilate, the prodrug of dabigatran, based on data obtained from healthy men to healthy non‐pregnant, pregnant and post‐partum women. To evaluate safety and efficacy of dabigatran etexilate in post‐partum women using simulations and design a future clinical study to
Kayode Ogungbenro +3 more
wiley +1 more source
Oesophageal Schwannoma: A Postoperative Diagnosis [PDF]
Oesophageal schwannomas are rare benign tumours with very few case reports in the literature. It is very difficult to diagnose these tumours preoperatively and is often confused with other benign tumours like leiomyomas and GIST.
Aditya Sharma +4 more
doaj +1 more source
Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?
Chronic viral hepatitis determines significant morbidity and mortality globally and is caused by three main etiological actors (Hepatitis B Virus, Hepatitis C Virus, and Hepatitis D Virus) with different replicative cycles and biological behaviors. Thus,
Giorgio Maria Saracco +2 more
doaj +1 more source
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale +5 more
wiley +1 more source
Background: Patients with chronic hepatitis C (CHC) and concomitant type 2 diabetes mellitus (DM) show a higher risk of developing hepatocellular carcinoma (HCC).
Marco Sacco +2 more
doaj +1 more source
Novel Bioactive Multifunctional Polyphenols: A Chemo‐Enzymatic Approach
One‐step synthesis of complex alkyl oxystilbenin glucosides (6‐47% yield) in alcoholic medium. Switching to ter‐BuOH as solvent afforded δ‐Viniferin diglucoside, with high selectivity and high yield (> 90%), that can be upgraded by enzymatic esterification to alkyl δ‐Viniferin diglucosides.
Amandine L. Flourat +8 more
wiley +1 more source

